Efficacy of teriparatide compared with risedronate on FRAX®-defined major osteoporotic fractures: results of the VERO clinical trial.
Jean-Jacques BodyFernando MarinDavid L KendlerCristiano Augusto Freitas ZerbiniPedro López-RomeroR MörickeEnrique Casado BurgosAstrid Fahrleitner-PammerJ J StepanEric LespessaillesSalvatore MinisolaPiet P M M GeusensPublished in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2020)
ClinicalTrials.gov Identifier: NCT01709110 EudraCT Number: 2012-000123-41.